Vous n'êtes pas connecté
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd yielded the highest pathological complete...
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd yielded the highest pathological complete...
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd yielded the highest pathological complete...
WEDNESDAY, Sept. 11, 2024 -- Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals,...
TUESDAY, Sept. 17, 2024 -- The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with...
By Chidinma Ewunonu-Aluko, Ibadan The National President of Association of Radiation and Clinical Oncologists in Nigeria (ARCON), Dr Nwamaka...
By Chidinma Ewunonu-AlukoThe National President of Association of Radiation and Clinical Oncologists in Nigeria (ARCON), Dr Nwamaka Lasebikan,...
[audio m4a="https://newsday.co.tt/wp-content/uploads/2024/09/BitDepth1476_Narration_16-09-2024.m4a"][/audio] BitDepth#1476 Mark Lyndersay A WEEK ago,...
[audio m4a="https://newsday.co.tt/wp-content/uploads/2024/09/BitDepth1476_Narration_16-09-2024.m4a"][/audio] BitDepth#1476 Mark Lyndersay A WEEK ago,...